Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests

Direct-to-consumer genetic tests (DTC-GT) have become a bridge between marketing and traditional healthcare services. After earning FDA endorsement for such facilities, several fast-developing companies started to compete in the related area. Pharmacogenomic (PGx) tests have been introduced as poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Tafazoli, Alireza, Guggilla, Rama Krishna, Kamel-Koleti, Zahra, Miltyk, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999840/
https://www.ncbi.nlm.nih.gov/pubmed/33802585
http://dx.doi.org/10.3390/genes12030361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999840/
https://www.ncbi.nlm.nih.gov/pubmed/33802585
http://dx.doi.org/10.3390/genes12030361

Ejemplares similares